Adenocarcinoma de cérvix en el segundo trimestre de embarazo

Vilar González, Elena; Orille Nuñez, Vicente Manuel; Rupilius Krautwig, Mayra Cecilia; Guzmán Cebrián, Mirella; Lorenzo Marcos, María Elena; Fernández Corona, Alfonso.
Prog. obstet. ginecol. (Ed. impr.) ; 58(9): 405-408, nov. 2015. ilus
Artículo en Español | IBECS (España) | ID: ibc-143478

Documentos relacionados

  1. [Observation of Child Development in a Uterine Cervical Cancer Patient Who Received Chemotherapy during Pregnancy].
  2. Aberrant expression of claudin-6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma.
  3. The potential of PCNA inhibition as a therapeutic strategy in cervical cancer.
  4. A successful case of neoadjuvant chemotherapy and radical hysterectomy during pregnancy for advanced uterine cervical cancer accompanied by neonatal erythroderma.
  5. Advances in the Management of Recurrent Cervical Cancer: State of the Art and Future Perspectives.
  6. Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
  7. In Vitro Prototyping of a Nano-Organogel for Thermo-Sonic Intra-Cervical Delivery of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles for Cervical Cancer.
  8. Medication-related problems among patients with cervical cancers at oncology centers of University of Gondar comprehensive specialized hospital: A hospital-based retrospective study.
  9. Characteristics of recent clinical investigations into systemic therapy against cervical cancer: systematic analysis of trial details from Clinicaltrials.gov.
  10. A cervical cancer biorepository for pharmacogenomics research in Zimbabwe.